project id: TCGA-PAAD; case submitter id: TCGA-3A-A9IV; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 8.4; age at index: 59; days to birth: -21732; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 21732; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1103.0; icd 10 code: C25.2; last known disease status: not reported; morphology: 8246/3; primary diagnosis: Neuroendocrine carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Yes; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 787; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-3A-A9IV-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;